Bayesian Capital Management, LP Bio Techne Corp Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $903,464 - $1.06 Million	13,693 New	13,693 $963,000
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $343,776 - $415,776	4,800 New	4,800 $356,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $328,758 - $398,232	-739 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $15,106 - $17,560	39 Added 5.57%	739 $333,000
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $220,234 - $287,700	700 New	700 $267,000

606

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.74B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.